← All organizations
Highest phase reached
Phase 4
Timeline
1990s
- Jun 1, 1995
Jiangsu Hansoh Pharmaceutical Co., Ltd.— Founded
2020s
- Apr 15, 2022
decitabine— Marketing Organization
Drugs by trial phase (114 distinct, 162 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (31 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Phase 1 (43 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Appendicitis
- Breast Neoplasms
- Carcinoma
- Carcinoma, Adenosquamous
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Communicable Diseases
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Infections
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Major Depressive Disorder
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Neoplasms
- Pelvic Infection
- Pelvic Inflammatory Disease
- Preleukemia
- Renal Insufficiency, Chronic
- Schizophrenia
- Syndrome
- Vomiting
Marketed drugs (11)
Recent trials (50)
- NCT07283367Lead sponsorPhase 1/Phase 2Dec 19, 2025
- NCT07186452Lead sponsorPhase 1Sep 30, 2025
- NCT07156539Lead sponsorPhase 3Sep 30, 2025
- NCT07115446Lead sponsorPhase 1Aug 31, 2025
- NCT07045155CollaboratorPhase 4Aug 1, 2025
- NCT07063407Lead sponsorPhase 1Jul 31, 2025
- NCT07097935Lead sponsorPhase 1/Phase 2Jul 10, 2025
- NCT07001787Lead sponsorPhase 1Jun 30, 2025
- NCT06844799Lead sponsorPhase 3Jun 10, 2025
- NCT06946394CollaboratorPhase 4May 31, 2025
- NCT06963502Lead sponsorPhase 1May 30, 2025
- NCT07040046Lead sponsorPhase 1May 16, 2025
- NCT07033234Lead sponsorPhase 1May 16, 2025
- NCT06963398Lead sponsorPhase 1May 15, 2025
- NCT06927570Lead sponsorPhase 1May 9, 2025
Details
- Founded
- Lianyungang, CN Jun 1, 1995
- Last known activity
- Dec 19, 2025